More Orthocell Ltd news
Orthocell LtdASX: OCC

Orthocells Ortho-ATI shows 82% success rate

Feb 12, 2019 at 11:04 PM EST · Issued by Orthocell Ltd

Filed with ASX · Feb 12, 2019 at 11:04 PM EST

On 6ix: 6ix.com/news/orthocells-ortho-ati-shows-82percent-success-rate

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Story so far

  • Orthocell Announces Successful Ortho-ATI Study ResultsJun 14, 2018
  • Ortho-ATI Case Study PublicationDec 8, 2017
  • 1st Patient Recruited in Ortho-ATI Shoulder Tendon StudySep 5, 2017

Earlier from Orthocell

  • CelGro Approved in Key UK Public Dental HospitalDec 10, 2018
  • Share Placement Successfully Raises $1.8mDec 10, 2018
  • Patient Treatment Completed in Dental Implant StudyNov 28, 2018
  • OCC Receives New Patents for Celgro Platform TechnologyNov 1, 2018
  • Investor UpdateOct 30, 2018

Later from Orthocell

  • Orthocell Submits AUS Regulatory Application for CelGroApr 30, 2019
  • First Patients Complete Nerve Regeneration TrialMay 7, 2019
  • Orthocell announces successful capital raisingMay 30, 2019
  • CelGro Accelerates Dental Implant TreatmentsJun 18, 2019
  • CelGro Study Validates High Quality Nerve RepairJul 25, 2019
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer